Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

Ndumele, Chiadi E., Rangaswami, Janani, Chow, Sheryl L., Neeland, Ian J., Tuttle, Katherine R., Khan, Sadiya S., Coresh, Josef, Mathew, Roy O. +22 more·2023·Circulation

DOI 10.1161/cir.0000000000001184

Cited by (1,000)

Items 501–600 of 1,000

Real-World Prescribing of Renal and Cardiovascular Protective Drugs in Patients With Type 2 Diabetes and Chronic Kidney Disease: Analysis of Data From a Western Australian Quaternary Hospital
Nick S.R. Lan, Ben McFadden, Andrew R. Johnson, Phillip Shedden, P. Gerry Fegan, Harish Puttagunta, Sharon Ho, Richard Gillett, Ramyasuda Swaminathan, Girish Dwivedi · 2025 · Heart Lung and Circulation
Impact of Maternal High-Fat Diet on Offspring Cardiovascular–Kidney–Metabolic Health: Spotlight on Oxidative Stress
Chien‐Ning Hsu, Chih‐Kuang Chen, Chih‐Yao Hou, Yu‐Wei Chen, Guo‐Ping Chang‐Chien, Shu-Fen Lin, You‐Lin Tain · 2025 · Antioxidants
Echoes of Inequity: A Critical Examination of the Past, Present, and Future of Cardiac Health Equity
T. Awoyemi, C. Mutebi, Q. Youmans, I. Okwuosa, Clyde W. Yancy, K. Ositelu · 2025 · Current Cardiology Reports
Temporal trends and machine learning prediction for chronic kidney disease due to hypertension in young adults from 1990 to 2021: an analysis of the global burden of disease study 2021
Yiqun Miao, Yuan Luo, Yuhan Zhao, Huiying Wang, Ying Xing Wu · 2025 · Annals of Medicine
Association between dietary inflammatory index and cardiovascular‑kidney‑metabolic syndrome: evidence from NHANES 1999–2018
Feng Chen, Z. Gu, Xiao-Gang Guo · 2025 · BMC Cardiovascular Disorders
Akkermansia muciniphila in Cardiometabolic Medicine: Mechanisms, Clinical Studies, and Therapeutic Outlook
Alireza FakhriRavari, Minh Hien Nguyen · 2025 · Gastrointestinal Disorders
Statins as Modulators of Epithelial to Mesenchymal Transition in Cardiovascular-Kidney-Metabolic Syndrome: a Comprehensive Review of Mechanisms and Therapeutic Implications
Fatemeh Askarizadeh, Wael A. Almahmeed, Kasim Sakran Abass, Salim S. Virani, Amirhossein Sahebkar · 2025 · Current Atherosclerosis Reports
Trends in nephrology: cardiovascular kidney-metabolic syndrome
Guobin Su, Biyi Liao, Yi Guo, Changyuan Yang, Natalie Staplin · 2025 · Nephrology Dialysis Transplantation
Cardiometabolic-Kidney Indices and Machine Learning Model for Predicting All-Cause Mortality in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Longitudinal Cohort Study
Yi Lu, Junfeng Ge, Lin Zhu, Lin Wang, Jiayuan Wu, Fengying Dong, Jin Deng · 2025 · American Journal of Nephrology
Association of body roundness index with cardiovascular disease in early Cardiovascular-Kidney-Metabolic syndrome stage 0–3: mediation by the triglyceride-glucose index in a national cohort study
Jiamiao Cai, Dongze Zheng, Sifan Xu, Shiyan Jiang, Yuxuan Jiang, Rou Zhang, Chenlin Li, Li Zhang, Bin Wang · 2025 · Diabetology & Metabolic Syndrome
The impact of gut-liver-derived mediators on the organ crosstalk with brain, heart, and kidney: A systematic review
Shruti Bhargava, Zhuangting Rao, Raymond Camille Vanholder, Frank Tacke, Heidi Noels, Vera Jankowski, Juliane Hermann, Joachim Jankowski · 2025 · Molecular Metabolism
Sex differences in the progression of cardiovascular–kidney–metabolic syndrome
Satoshi Taya, Kentaro Ejiri, Hidehiro Kaneko, Yuta Suzuki, Toru Miyoshi, Atsushi Mizuno, Toshiyuki Ko, Takahiro Jimba, Tatsuhiko Azegami, Akira Okada et al. · 2025 · European Heart Journal Open
Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis are Associated with Advanced Cardiovascular-Kidney-Metabolic Syndrome in Chinese and US Populations
Shidi Hu, Dong Wang, Qingtao Yu, Zhi Chen, Weiguo Lu, Yuan Meng, Xuetao Peng, Lan Liu, Heng Wan, Jie Shen · 2025 · Diabetes Metabolic Syndrome and Obesity
Immune Inflammation at the Crossroads of Atherosclerosis and Ischemic Stroke: Mechanisms, Trends, and Translational Perspectives
Hongdong Hao, Dian Chen, Cheng Qian, Xuanyi Zhou, Xi Peng, Guanlin Wang, Jingjing Tang, Hai‐Xin Liu · 2025 · CNS Neuroscience & Therapeutics
Associations between sarcopenic obesity and the risk of cardiovascular-kidney-metabolic syndrome progression: insights from the China health and retirement longitudinal study
Yijing Xin, Xifeng Qian, Y J Yang · 2025 · Diabetology & Metabolic Syndrome
Comparative safety profiles of spironolactone, eplerenone, and finerenone: a pharmacovigilance study based on FAERS data from 2004 to 2024
Kaiyun Ji, Xingjun Huang, Fang Wang, Lei Zhang, Yifan Zheng, Ligang Ji, Ying Ju, Xiaodong Zhuang, Jia Li · 2026 · Frontiers in Pharmacology
Hypertriglyceridemia in chronic kidney disease: pathophysiological mechanisms, cardiovascular risk, and emerging therapeutics
Dandan Li, Zhanju Liu, Hongwei Jiang · 2026 · Lipids in Health and Disease
Liver fibrosis biomarkers as a prognostic tool beyond the defining components in cardiovascular-kidney-metabolic syndrome
ZhiHeng Cao, Binyan Chen, Jinghao Zhou, Jijie Jin, Dmitry Abramov, Shengzhang Chen, Pan Huang, Jianghua Zhou · 2026 · American Journal of Preventive Cardiology
Sex differences in cardiovascular-kidney-metabolic syndrome and new onset cardiovascular outcomes
Lin Liu, Anping Cai, Kevin Chun Hei Wu, Ai Min Xu, Gregory Y.H. Lip, Yunjiu Cheng, Bernard M.Y. Cheung, Kai‐Hang Yiu · 2026 · Metabolism
Metabolic liver disease: A summary of major guidelines and identifying opportunities to improve future guidelines
Fernando Bril · 2026 · Diabetes Obesity and Metabolism
WHF Roadmap for Integrated Care in People Living with – or at Risk of – Cardiovascular Disease and Multiple Long-Term Conditions
Laurence S. Sperling, Vilma Edith Irazola, Jackie Partarrieu, Lana Raspail, Maciej Banach, Amitava Banerjee, Gene Bukhman, Maria George, Eri Toda Kato, Francisco Alejandro López-Jiménez et al. · 2026 · Global Heart
Cardiovascular-kidney-metabolic syndrome and atrial fibrillation: Insights from 2 real-world prospective registries across Europe and East Asia
Amir Askarinejad, Tommaso Bucci, Enrico Tartaglia, Michele Rossi, Andrea Galeazzo Rigutini, Hung-Fat Tse Tse, Giuseppe Boriani, Tze‐Fan Chao, Gregory Y.H. Lip · 2026 · Heart Rhythm
Performance of PREVENT Cardiovascular Risk in Electronic Health Record–Based Clinical Practice
Chuan Hong, Mu Niu, Hao-Yuan Wang, Daniel M. Wojdyla, Nicoleta J. Economou-Zavlanos, Matthew Engelhard, M. Pignone, Manesh R. Patel, M. Pencina · 2026 · JAMA Network Open
Advances in the diagnosis and detection of chronic kidney disease
Jennifer Susan Lees, Luxia Zhang, Urmila Anandh, Andreas Kronbichler, Lori-Ann Fisher, Matthew Borg, Angela Yee-Moon Wang, Adeera Levin · 2026 · The Lancet
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Sadiya S. Khan, Nicole Martin Bhave, Roger Scott Blumenthal, Josef Coresh, Xiaoning Huang, Joshua J. Joseph, Amit Khera, Jennifer E. Ho, Donald M. Lloyd‐Jones, Cecilia C. Low Wang et al. · 2026 · Circulation
Association of Frailty and Its Trajectories With the Risk of Cardiovascular–Kidney–Metabolic Syndrome Progression: A Longitudinal Cohort Study
Haoyu Yang, Zi Wang, Wuyong Yi, Ling Men, Riming He, Shudong Yang · 2026 · Geriatrics and gerontology international/Geriatrics & gerontology international
Hypertension and the kidney: an update
Luis Miguel Ruilope, Alberto Ortíz, Gema Ruiz‐Hurtado · 2024 · European Heart Journal
Advances in Clinical Cardiology 2023: A Summary of Key Clinical Trials
Patrick Savage, Brian Cox, Michael Shahmohammadi, Bronagh P. Kelly, Ian B A Menown · 2024 · Advances in Therapy
Effective Strategies and a Ten-Point Plan for Cardio-Kidney-Metabolic Health in Croatia: An Expert Opinion
Željko Reiner, Bojan Jelaković, Davor Milicić, Marija Bubaš, Ines Balint, Nikolina Bašić‐Jukić, Valerija Bralić Lang, Vili Beroš, Ivana Brkić Biloš, Silvija Canecki-Varžić et al. · 2024 · Journal of Clinical Medicine
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Body Composition and Fluid Status in Cardiovascular Rehabilitation Patients with Coronary Artery Disease and Heart Failure
Jose Carlos de la Flor, B Coto Morales, Elena Basabe Velasco, María Rey Hernandez, Rocío Zamora González-Mariño, Celia Rodríguez Tudero, Irwing R. Benites-Flores, Carlos Vladimir Espinoza, Michael Cieza Terrones, Secundino Cigarrán Guldris et al. · 2024 · Medicina
A New Model of Chronic Kidney Disease, Metabolic Derangements, and Heart Failure with Preserved Ejection Fraction in Aging Swine
Alejandro Chade, Darla L. Tharp, Rhys Sitz, Elizabeth A. McCarthy, Kumar Shivam, Sara Kazeminia, Alfonso Eirin · 2025 · American Journal of Nephrology
Closing the Gap: Digital Innovations to Address Hypertension Disparities
Bassel M. Shanab, Allison E. Gaffey, Lee H. Schwamm, Matthew Zawalich, Daniel F. Sarpong, Rafael Pérez‐Escamilla, Jocelyn Dorney, Charlotte Cooperman, Ryan Schafer, Heather S. Lipkind et al. · 2025 · Current Cardiology Reports
The association between county-level social determinants of health and cardio-kidney-metabolic disease attributed all-cause mortality in the US: A cross sectional analysis
Antoinette Cotton, Pedro Rafael Vieira de Oliveira Salerno, Salil Vasudeo Deo, Salim S. Virani, Khurram Nasir, Ian J. Neeland, Sanjay Rajagopalan, Naveed A. Sattar, Sadeer G Al-Kindi, Yakov E. Elgudin · 2025 · The American Journal of the Medical Sciences
Diet quality and cardiometabolic health in breast cancer survivors: the Pathways Study
Isaac Joshua Ergas, Richard Kar-Hang Cheng, Janise M. Roh, Jacob K. Kresovich, Carlos Iribarren, Mai N. Nguyen‐Huynh, Jamal S. Rana, Eileen Rillamas‐Sun, Cecile A. Laurent, Valerie S. Lee et al. · 2025 · Breast Cancer Research and Treatment
The Combined Effect of Smoking and Obesity on Hypertension: Implications for Clinical Management
Dimitrios Aragiannis, Alexandros Kasiakogias, Panagιotis Iliakis, Μarios Sagris, Fotios Panagiotis Tatakis, Eleni Manta, Ioannis Andrikou, Dimitrios Konstantinidis, Konstantinos P Tsioufis · 2025 · Current Hypertension Reviews
Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health: A Presidential Advisory From the American Heart Association
Joseph C. Wu, Donna K. Arnett, Ivor J. Benjamin, Mark A. Creager, Robert A. Harrington, Joseph A. Hill, P. Michael Ho, Steven R. Houser, Stephanie Scarmo, Svati Hasmukh Shah et al. · 2025 · Circulation
Chronic kidney disease is no longer a ‘non-traditional’ cardiac risk factor: a call to action for cardiovascular-kidney-metabolic health
Jie Ming Nigel Fong, Ching‐Hui Sia, Kay Choong See · 2025 · Singapore Medical Journal
Cardiovascular disease and female sexual health across the life span: a bidirectional link
Anastasia K. Armeni, Eleni Armeni, Peter A. Chedraui, Irene V. Lambrinoudaki · 2025 · Maturitas
The FDA and the Cardiovascular Community
Haider Javed Warraich, Robert M. Califf · 2024 · Journal of the American College of Cardiology
Secular Trends in Hip Fracture Mortality and Predictors of Mortality From the NSQIP Database
Caline Rhayem, Aya Ghosn, Zeinab Ali Issa, Joudie Sahar Alwan, Hani I. Dimassi, Rachid Haidar, Ghada El‐Hajj Fuleihan · 2025 · The Journal of Clinical Endocrinology & Metabolism
Association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in population with cardiovascular-kidney-metabolic syndrome stages 0–4: evidence from a large cohort study
Fan-Shun Guo, Jia‐Hao Dou, Jun-Xiang Wang, Chen Yang Guo, Rui‐Yun Wu, Xue-Lu Sun, Yi-Wei Hu, Jin Wei · 2025 · Diabetology & Metabolic Syndrome
The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes
Lübker, Christopher, Bhavsar, Jigish, Duque do Vale, Ruben, Emerson, Scott S., Nørtoft, Emil, Plutzky, Jorge, Roberts, Geraint, Tarp, Jens Magelund, Lincoff, A. Michael · 2025 · Advances in Therapy
A passive flow microreactor for urine creatinine test
Dumitru Tomsa, Yang Liu, Amanda L. Stefanson, Xiaoou Ren, AbdulRazaq A. H. Sokoro, Paul V. J. Komenda, Navdeep Tangri, René Peiman Zahedi, Claudio Rigatto, Francis Lin · 2025 · Microsystems & Nanoengineering
Lithium in cardiovascular health and disease: Pharmacological and clinical implications
Jingya Jiang, Wanbing He, Hui Huang · 2025 · European Journal of Pharmacology
Association between the triglyceride glucose index and long-term outcomes in patients with acute coronary syndrome and chronic kidney disease
Feng Wang, Wendi Huang, Chonghao Shi, Yongfu Zhu, Weicheng Ni · 2025 · Diabetology & Metabolic Syndrome
Identifying potential drugs for treating Cardiovascular-kidney metabolic syndrome via reverse network pharmacology
Siao Wen, Ao-Ni Fu, Fen Liu, Yayu You, Linkai Li, Wen Xiao, Haoran Zhong, Xiuqin Hong, Xin Zhong, Yongjun Jeff Hu et al. · 2025 · Frontiers in Pharmacology
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Stage 4 Cardiovascular–Kidney–Metabolic Syndrome: A Propensity Score–Matched Study
Tao Liu, Zeyuan Fan, Yuntao Li, Bing Xiao, He Chang · 2025 · Journal of the American Heart Association
Social Determinants of Health and Mortality in Cardiovascular-Kidney-Metabolic Syndrome
Ryan P. Chang, Zulqarnain Javed, John W. Ostrominski, Jerrin S. Philip, Sheikh B. Khalid, Oluwabunmi Ogungbe, Lucia Canales, Elias A. Mossialos, Sadeer G Al-Kindi, Khurram Nasir · 2025 · JACC Advances
Targeting serum phosphate trajectory stratification to improve outcomes in high-risk Cardiovascular-Kidney-Metabolic-Sepsis cohorts
Jinwei Dai, Wangshu Xu, Nianzhe Sun, Ting Wu, Zhaoxin Qian, Zhihong Zuo · 2025 · PLoS ONE
Cardiovascular-kidney-metabolic syndrome stage predicts cardiovascular outcomes in cancer patients: a real-world data analysis of a nationwide epidemiological dataset
Toshiyuki Ko, Yuta Suzuki, Hidehiro Kaneko, Akira Okada, Takahiro Jimba, Tatsuhiko Azegami, Atsushi Mizuno, Kentaro Ejiri, Katsuhito Fujiu, Norifumi Takeda et al. · 2025 · European Heart Journal Open
Environment-wide association study of cardiovascular-kidney-metabolic syndrome based on NHANES 2013–2016
Jianhua Ma, Pingan Li, Lixin Tao, Xinghua Yang, Yanxia Luo, Xiuhua Guo, Bo Gao · 2025 · Ecotoxicology and Environmental Safety
Role of Morbidity Clusters in Midlife on Ischemic Stroke Incidence and Severity: The ARIC Study
Marco S. Egle, Renée C. Groechel, Michelle C. Johansen, Anna Kucharska‐Newton, Rebecca F. Gottesman, Silvia Koton · 2025 · Stroke
Joint association of plasma ceramide and renal function with coronary artery lesion severity: The CRUISE-MET study
Qiang Chen, Yike Li, Haoming He, Yingying Xie, Dongliang Fu, Ruilong Gao, Nan Li, Sunjin Fu, Mu Yuan, Yuxuan Sun et al. · 2025 · Journal of clinical lipidology
Associations Between Hematologic Parameters and All‐Cause Death in Individuals With Cardio‐Renal–Metabolic Multimorbidity: A National Cohort Study
Song Wen, Shuheng Zhou, Wei Wang, Xueting Qiu, Yingqing Feng · 2025 · Journal of the American Heart Association
Bidirectional association between chronic liver disease and chronic kidney disease: a longitudinal study based on CHARLS 2011–2020 data
Yuan He, Fan Zhang, Zixuan Zhang, Xianwen Zhang, Yifei Zhong · 2025 · Annals of Hepatology
Addressing the “Nitric Oxide Crisis” in Cardiovascular–Kidney–Metabolic Syndrome: Therapeutic Potential of the Inorganic Nitrate–Nitrite–NO Pathway
Guang‐zhi Liao, Chunhui He, Yuhui Zhang, Jian Zhang · 2025 · Obesity Reviews
Using the American heart association's new 'cardiovascular-kidney-metabolic syndrome' metrics to assess life expectancy in us adults: A life table analysis
Zhendong Cheng, Wenqing Xu, Jianping Luo, Xianghui Zeng, Qingfeng Zeng, Gang Cao, Guosheng Liu, Chunqing Xiao · 2025 · American Journal of Preventive Cardiology
Attention-based synthetic data generation for calibration-enhanced survival analysis: A case study for chronic kidney disease using electronic health records
Nicholas I-Hsien Kuo, Blanca Gallego, Louisa R. Jorm · 2025 · Journal of Biomedical Informatics
Association between 10-year atherosclerotic cardiovascular disease risk score and incident cardiovascular events across stages 0–3 of cardiovascular–kidney–metabolic syndrome: evidence from the China health and retirement longitudinal study (CHARLS)
Zhitong Li, Wenxia Ren, Xuhui Li, Ruixue Duan, Linlin Gao, Jiaojiao Li, Yajing Bai, Yuanyuan Yan, Angxian Lü, Anqi Zhao et al. · 2025 · BMC Cardiovascular Disorders
Association of the cardiovascular–kidney–metabolic syndrome and adverse outcomes after noncardiac surgery
Laurent G. Glance, Karen E. Joynt Maddox, Shaelyn M. Cavanaugh, Peter A. Knight, Michael A. Mazzeffi, Jingjing Shang, Patricia W. Stone, Stewart J. Lustik, Kunal Panda, Melissa A. Kreso et al. · 2025 · British Journal of Anaesthesia
Cardiovascular-kidney-metabolic syndrome, dementia risk, cognition, and neuroimaging outcomes
Qida He, Mengtong Sun, Qi Wang, Jingting Huang, Shaoshan Hu, Yueping Shen, Linyan Li · 2025 · Journal of Affective Disorders
Pro-inflammatory and pro-oxidant diets and CKD risk across cardiovascular–kidney–metabolic syndrome stages: a multi-omics mediation analysis
Yiwei Zhang, Yuying Huang, Xiaoqin Gan, Sisi Yang, Yanjun Zhang, Yiting Wu, Ziliang Ye, Xianglian Cai, D.W. Chen, Xiaolong Liang et al. · 2025 · Food & Function
GLP1-RAs: long-term use versus discontinuation events of an emerging therapy for obesity and cardiovascular diseases
Edward Salerno, Isabella Fumarulo, Barbara Garramone, Marcello Vaccarella, Carolina Ierardi, Francesco Burzotta, Nadia Aspromonte · 2025 · Current Problems in Cardiology
METS-IR predicts new-onset stroke in older adults with stages 0–3 cardiovascular-kidney-metabolic syndrome: a prospective, multicohort, clinical study with statistical and machine learning
Yikang Wang, Qi Yu · 2025 · Diabetology & Metabolic Syndrome
Effect of Glucagon‐Like Peptide‐1 Receptor Agonists on Cardiometabolic Risk Factors in Type 1 Diabetes Mellitus: A Systematic Review and Meta‐Analysis
Yizhu Chen, Yu-Fei Tang, Rui Yue, Bo Yang, Ai-Hong Wang, Yang Long, Yong Xu, Chen-Lin Gao · 2025 · Diabetes/Metabolism Research Reviews
Effects of dapagliflozin on mortality across the spectrum of cardiovascular-kidney-metabolic syndrome: a meta-analysis
Stefania Paolillo, Federica Marzano, Dario Bruzzese, Mariafrancesca Di Santo, Ermanno Nardi, Gaetano Asile, Ciro Cotticelli, Fabrizio Perrone Filardi, Sara Fontanarosa, Maddalena Smarrazzo et al. · 2025 · Nutrition Metabolism and Cardiovascular Diseases
Sarcopenia risk along the cardiovascular-kidney-metabolic syndrome spectrum: synergistic effects of multisystem burden and physical inactivity
Dingding Wang, Meng Zhang, Qinghua Fan, Jianwen Yu, Jianbo Li, Lanping Jiang, Xunhua Zheng, Siyang Ye, Suchun Li, Peichen Xie et al. · 2025 · BMC Public Health
Circulating Extracellular Vesicle MicroRNAs as Predictive Biomarkers for Kidney and Cardiovascular Events
Shunsuke Inaba, Takanori Hasegawa, Yuta Nakano, Shotaro Naito, Rena Suzukawa, Takaaki Koide, Hisateru Sekiya, Hisazumi Matsuki, Tamami Fujiki, Hiroaki Kikuchi et al. · 2025 · Journal of the American Heart Association
Associations between the triglyceride glucose-body roundness index and frailty trajectory in populations with cardiovascular–kidney–metabolic syndrome: a nationwide prospective cohort study
Zhongmin Fu, Shulin Song, Yan Ji, Lisi Duan, Ziyan Wang, Yue Chen, Yinning Guo, Kang Zhao, Xinyi Xu, Changqing Wang et al. · 2025 · The Journals of Gerontology Series A
Advances in risk prediction and treatment strategies for CKM syndrome
Yelena R. Drexler, Alessia Fornoni · 2025 · Nature Reviews Nephrology
Joint associations of accelerometer-measured physical activity and cardiovascular-kidney-metabolic syndrome stages with the risks of cancer and all-cause mortality
Jia-Cheng Liu, Rui Yang, Zan-Fei Feng, Bang-Quan Liu, Li Yu, Yu-Han Chen, Dong-Run Li, Wen-Rui Zheng, Ning Liu, Shan‐Yan Gao et al. · 2025 · JNCI Journal of the National Cancer Institute
Translational Lifestyle Medicine Approaches to Cardiovascular–Kidney–Metabolic Syndrome
Z. Papadakis · 2025 · Healthcare
Rest-activity rhythms and cardiovascular events in cardiovascular–kidney–metabolic syndrome: evidence from two nationwide cohorts
Bingtao Weng, Haizhen Chen, Han Chen, Ningjian Wang, Hongliang Feng, Kehua Yang, Xiao Tan · 2026 · American Journal of Preventive Cardiology
Association between the triglyceride-glucose-frailty index and all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: the mediating role of the poverty-income ratio
Yan Wang, Na Wei, Meng Li, Jun-Wen Liu, Hong-Bin Lin, Hongfei Zhang · 2026 · Cardiovascular Diabetology
Cost-Effectiveness of Semaglutide for Secondary Prevention of Cardiovascular Disease in US Adults
Susan S. Hennessy, Joanne M. Penko, Brandon Kyle Bellows, Pamela G. Coxson, Ross D. Boylan, Kendra D. Sims, Alexis L. Beatty, Kosuke Inoue, Ivy Shi, Sérgio Renato da Rosa Decker et al. · 2026 · JAMA Cardiology
Heart Failure Prevention
Javed Butler, Muhammad Shahzeb Khan, João Pedro Ferreira, Nicolas Girerd, Martha Gulati, Anuradha Lala, Mark Colquhoun Petrie, Norman Stockbridge, Muthiah Vaduganathan, Faiez M. Zannad · 2026 · Journal of the American College of Cardiology
Glycaemic control remains central in type 2 diabetes mellitus management: key learnings from the latest International Diabetes Federation guidelines
Juliana C.N. Chan, Chaicharn Deerochanawong, Kamlesh Khunti, Mohamed M. Hassanein, Viswanathan Mohan · 2026 · Diabetes Research and Clinical Practice
Sex-specific associations between depression and cardiovascular–kidney–metabolic syndrome progression: a national cohort study
Qi Gao, Weirong Ren, Xingguo Du, Yaping Yu, Zhou Ma, Yan Cui, Xiaohong Song, Zhongcai Wu, Zhiqin Zhang, Qianqian Liao et al. · 2026 · European Journal of Preventive Cardiology
Chronic Inflammation as an Overlooked Link between Cardiovascular and Kidney Disease
Pablo E. Pérgola, Richard J. Johnson, Adeera Levin, Peter Stenvinkel · 2026 · Clinical Journal of the American Society of Nephrology
Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3
Bingtao Weng, Jiahe Wei, Han Chen, Yuyan Zhao, Ningjian Wang, Hongliang Feng, Sizhi Ai, Xiao Tan · 2026 · Metabolism
Sex differences in cardiovascular–kidney–metabolic syndrome: the FINE-HEART pooled analysis
Maria A. Pabón, John W. Ostrominski, Xiaowen Wang, Brian Lee Claggett, Kevin Bryan Lo, Gerasimos S Filippatos, Akshay Suvas Desai, Pardeep S. Jhund, Alaisdair Henderson, Carolyn S.P. Lam et al. · 2026 · European Heart Journal
Excess and Dysfunctional Fat as a Primary Driver of Heart Failure With Preserved Ejection Fraction
Milton Packer, Jennifer E. Ho, Mark Colquhoun Petrie, Gabriele G. Schiattarella, Javed Butler, Carolyn S.P. Lam, Muthiah Vaduganathan, Faiez M. Zannad, Barry A. Borlaug · 2026 · JACC Heart Failure
Association of cardiovascular-kidney-metabolic syndrome with cardiovascular, cancer, and all-cause mortality among US adults: A prospective study
Cheng Zhang, Xuebo Li, Ying Liu · 2026 · Journal of the Formosan Medical Association
Implementing sodium–glucose co-transporter 2 inhibitors in cardiovascular–kidney–metabolic syndrome: a multidisciplinary expert perspective
Angelo Avogaro, Mauro Gori, Giuseppe Grandaliano, Massimo Iacoviello, Roberto Trevisan · 2026 · European Heart Journal - Cardiovascular Pharmacotherapy
Emerging multidimensional biomarker system for cardiovascular-kidney-metabolic syndrome: from multi-omics integration to clinical artificial intelligence
Fei-Hong Li, Y S Li, Yue Zhang, Liu Yang, Shaokang Pan, D W Liu, Z.H. Liu, Zhong‐Xiuzi Gao, Peng Wu · 2026 · Cardiovascular Diabetology
Joint association of atherogenic index of plasma and estimated glucose disposal rate with new-onset cardiovascular disease risk in individuals with cardiovascular–kidney–metabolic syndrome stages 0–3: a 9-year nationwide prospective cohort study
Yuhang Fan, Zhibo Si, Miaomiao Wei, Yumeng Gu, Xin Li · 2026 · Cardiovascular Diabetology
Chronic kidney disease, complex conditions, and advancing therapeutics: new hope and challenges
Jennifer Susan Lees, Andrej Škoberne, Luxia Zhang, Christina Wyatt, June Fabian, Angela Yee-Moon Wang, Louise Oni, Adeera Levin · 2026 · The Lancet
Advances in understanding the impact of sex on kidney health and disease
Jennifer Susan Lees, Kate I Stevens, Sradha S. Kotwal, Annette N. Bruchfeld, Adeera Levin · 2026 · The Lancet
Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial
Virginia Bellido, Carel Wynand le Roux, Elif Ilhan Ekinci, Petter Bjornstad, Juan P. Frías, Kathryn A. Giblin, Sarah Eyde, So Young Park, Joao Ferro, Caroline Johnson et al. · 2026 · The Lancet
Cost Offset of Dapagliflozin in the US Medicare Population with Cardio-Kidney Metabolic Syndrome
Raymond Chuen‐Chung Chang, Ryan L. Miller, Katherine W. Kwon, Joanna Huang · 2024 · Advances in Therapy
Optimizing Cardiovascular Health: A Comprehensive Review of Risk Assessment Strategies for Primary Prevention
Vineet Karwa, Anil Wanjari, Sunil Kumar, Rushikesh H Dhondge, Rajvardhan Patil, Manjeet Kothari · 2024 · Cureus
Atrial Fibrillation Prevalence Rates and Its Association with Cardiovascular–Kidney–Metabolic Factors: SIMETAP-AF Study
Antonio Ruiz‐García, Adalberto Serrano-Cumplido, Carlos Escobar, Ezequiel Arranz-Martínez, Vicente Pallarés‐Carratalá · 2024 · Medicina
Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease
Davide Ramoni, Luca Liberale, Fabrizio Montecucco · 2024 · World Journal of Gastroenterology
Type 2 diabetes and chronic kidney disease as long‐term predictors of cardiovascular events in patients with coronary artery disease
LAURA SCHNETZER, Andreas Leiherer, Andreas Festa, Axel Mündlein, THOMAS PLATTNER, Gert J. Mayer, Christoph H. Saely, Heinz Drexel · 2024 · European Journal of Clinical Investigation
Associations between Multimorbidity and the Risks of Cardiovascular Disease Events and All-Cause Mortality in Patients with Chronic Kidney Disease
Kazuhiro Okamura, Shigeru Tanaka, Hiromasa Kitamura, Tatsuya Suenaga, Kazuhiko Tsuruya, Takanari Kitazono, Toshiaki Nakano · 2025 · American Journal of Nephrology
Association of cardiovascular-kidney-metabolic health and apolipoprotein E4 genotype with risk of dementia and mortality
Xinghe Huang, Jie Liang, J Y Zhang, Jiayi Fu, Yige Chen, Wuxiang Xie, Fanfan Zheng · 2025 · Journal of Alzheimer s Disease
AI-enabled opportunistic measurement of liver steatosis in coronary artery calcium scans predicts cardiovascular events and all-cause mortality: an AI-CVD study within the Multi-Ethnic Study of Atherosclerosis (MESA)
Morteza Naghavi, Kyle C. Atlas, Anthony P. Reeves, Chenyu Zhang, Jakob Wasserthal, Thomas L. Atlas, Claudia I. Henschke, David F. Yankelevitz, Javier J. Zulueta, Matthew Jay Budoff et al. · 2025 · BMJ Open Diabetes Research & Care
Correlation between conventional and unconventional lipid parameters with the risk of progression of renal function decline: insights from the China Health and Retirement Longitudinal Study 2011–2015
Y. Xin, Yi-Meng Wang, Yu-Yuan Shu, Han-Yang Liang, Yan-Min Yang · 2025 · Renal Failure
Physical Activity and Exercise for Cardiometabolic Health and Fitness in CKD
Brandon M. Kistler, Danielle L. Kirkman, Dave Kusni, Geovana Martin Alemañy, Heitor S. Ribeiro, Brett D. Tarca, Stephanie Thompson, João L. Viana, Thomas James Wilkinson, Ken Wilund · 2025 · Clinical Journal of the American Society of Nephrology
Disrupted bilirubin metabolism and gut microbiome dysregulation: A link to cardio-renal-hepatic-metabolic health in obstructive sleep apnea
Mohit Mohit, Jayhind Maury, Jyoti Bajpai, Sheetal Verma · 2025 · Life Sciences